CLM3
CLM3 is a pyrazolopyrimidine-based multi-target tyrosine kinase inhibitor that suppresses proliferation and induces apoptosis in endothelial and cancer cells by blocking VEGFR-2, EGFR, and RET phosphorylation. Its activity is synergistically enhanced with SN38, supporting its use in oncology research for in vitro and in vivo studies of angiogenesis and tumor growth signaling pathways.
Product Specifications
CAS Number
1312024-59-1
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Smiles
N ([C@H] (C) C1=CC=CC=C1) C2=C3C (N (CCC4=CC=CC=C4) N=C3) =NC=N2
Molecular Formula
C21H21N5
Molecular Weight
343.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
044551 100 µg
ANGPTL7 (Angiopoietin-like Protein 7, Cornea-derived Transcript 6 Protein)
Sign In for Pricing
View Details I0466-10A 50 µg
IBRDC2 (E3 Ubiquitin-protein Ligase RNF144B, IBR Domain-containing Protein 2, RING Finger Protein 144B, p53-inducible RING Finger Protein, RNF144B, P53RFP) discontinued
Sign In for Pricing
View Details